Results 121 to 130 of about 1,983,235 (163)

Low Absolute Lymphocyte Count Associated With Anti-Thymocyte Globulin Induction May Be a Predictor of Early Cytomegalovirus Infection in Pediatric Heart Transplantation. [PDF]

Pediatr Transplant
Chan A, Tan R, Tan S, Kuhn M, Shwaish N, Chinnock R, Tran H, Frandsen E.   +7 more
europepmc   +1 more source

Early and Long-Lasting Hematologic Recovery in a Young Adult With Severe Aplastic Anemia Treated With Romiplostim, Horse-Anti-Thymocyte Globulin (ATG), and Cyclosporine A: A Case Report. [PDF]

Cureus
Kakizaki E, Higashi T, Akao K, Morimoto H, Tsukada J.   +4 more
europepmc   +1 more source

Randomized trial of anti-thymocyte globulin plus lowdose post-transplant cyclophosphamide to prevent graft-<i>versus</i>- host disease in haploidentical transplantation. [PDF]

Haematologica
Xu ZL, Han TT, Zhu XL, Liu J, Lv M, Sun YQ, Mo XD, Cheng YF, Xu LP, Zhang XH, Huang XJ, Wang Y.   +11 more
europepmc   +1 more source

Anti-thymocyte globulin-based treatment frequently leads to enduring treatment success in both old and young adult patients with aplastic anaemia: a real-world analysis from the Dutch aplastic anaemia registry. [PDF]

Ann Hematol
Halkes CJM, Koster EAS, Bogers EJM, Heubel-Moenen FCJI, Daenen LGM, Klein SK, Langemeijer SMC, Nur E, Raaijmakers MHG, Snijders TJF, Tjon JML, de Wreede LC.   +11 more
europepmc   +1 more source

Low-dose anti-thymocyte globulin combined with low-dose post-transplant cyclophosphamide: a novel approach to prevent graft-versus-host disease in haploidentical stem cell transplantation. [PDF]

Ther Adv Hematol
Mandaci Ṣanli N, Ünal A.
europepmc   +1 more source

Post-transplant cyclophosphamide versus anti-thymocyte globulin in haploidentical stem cell transplantation: a systematic review and meta-analysis. [PDF]

Ann Hematol
Jin X, Yang Y, Chen X.
europepmc   +1 more source

Basiliximab is superior to low dose rabbit anti-thymocyte globulin in pediatric kidney transplant recipients: The younger, the better. [PDF]

Chin Med J (Engl)
Zhu L, Zhang L, Shang W, Liu W, Sa R, Guo Z, Liu L, Tan J, Zhang H, Feng Y, Zhao W, Cong W, Wu J, Wang C, Chen G.   +14 more
europepmc   +1 more source

Multicenter, Real-World Clinical Evaluation of Alemtuzumab and Anti-Thymocyte Globulin for Severe Acute T Cell-Mediated Kidney Transplant Rejection. [PDF]

Clin Transplant
van Vugt LK, Tegzess E, van der Zwan M, Clahsen-van Groningen MC, de Winter BCM, Vart P, Reinders MEJ, Sanders JSF, Berger SP, Hesselink DA.   +9 more
europepmc   +1 more source

Anti-thymocyte globulin (ATG)- or alemtuzumab-based graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic hematopoietic cell transplantation (HCT) for patients 40 years and older with acute lymphoblastic leukemia in first complete remission: a study from the EBMT Acute Leukemia Working Party. [PDF]

Bone Marrow Transplant
Bug G, Labopin M, Byrne JL, Mielke S, Orchard K, Paneesha S, Potter V, Blaise D, Besley C, Snowden JA, Yakoub-Agha I, Clark A, Crawley C, Spyridonidis A, Sanz J, Brissot E, Giebel S, Ciceri F, Mohty M.   +18 more
europepmc   +1 more source

Immune reconstitution dynamics after unrelated allogeneic transplantation with post-transplant cyclophosphamide compared to classical immunosuppression with anti-thymocyte globulin: a prospective cohort study. [PDF]

Haematologica
Kerbauy MN, Rocha FA, Arcuri LJ, Cunegundes PS, Kerbauy LN, Machado CM, Ribeiro AAF, Banerjee PP, Marti LC, Hamerschlak N.   +9 more
europepmc   +1 more source